DaVita HealthCare Partners Inc. (NYSE:DVA) reported Q2 2017 earnings this Afternoon, coming in at $0.92 per share, beating Wall Street’s estimates of $0.90 per Share. Revenue for the quarter came in at $3.88 billion beating analyst estimates of $3.82 billion
Analyst Coverage For DaVita HealthCare Partners Inc. (NYSE:DVA)
These are 1 Sell Rating, 7 Hold Ratings, 2 Buy Ratings .
The current consensus rating for DaVita HealthCare Partners Inc. (NYSE:DVA) is Hold (Score: 2.10) with a consensus target price of $68.67 , a potential (7.07% upside)Recent Insider Trading for DaVita HealthCare Partners Inc. (NYSE:DVA)
- On 5/15/2017 Javier Rodriguez, CEO, sold 1,294 with an average share price of $66.21 per share and the total transaction amounting to $85,675.74.
- On 5/9/2017 Charles Berg, Director, sold 8,414 with an average share price of $65.80 per share and the total transaction amounting to $553,641.20.
- On 5/4/2017 William L Roper, Director, sold 12,994 with an average share price of $65.89 per share and the total transaction amounting to $856,174.66.
- On 8/9/2016 Michael David Staffieri, COO, sold 20,262 with an average share price of $73.09 per share and the total transaction amounting to $1,480,949.58.
- On 7/11/2016 Jeanine Marie Jiganti, Insider, sold 1,291 with an average share price of $78.51 per share and the total transaction amounting to $101,356.41.
- On 7/1/2016 Jeanine Marie Jiganti, Insider, sold 4,620 with an average share price of $77.45 per share and the total transaction amounting to $357,819.00.
Recent Trading for DaVita HealthCare Partners Inc. (NYSE:DVA) Shares of DaVita HealthCare Partners Inc. closed the previous trading session at 64.13 down -0.65 -1.00% with 1,666,698 shares trading hands.